Maple Gold arranges $16-million in private placements

Executive Summary

• Maple Gold Mines Ltd. announced a combined capital raise of up to $16 million, consisting of a $12 million brokered Listed Issuer Financing Exemption (LIFE) offering and a concurrent $4 million non-brokered private placement.
• The brokered portion involves the issuance of up to 3,525,000 flow-through shares at $3.40 per share, with Canaccord Genuity Corp. acting as lead agent.
• The concurrent non-brokered private placement includes up to 1,070,960 flow-through shares and up to 152,580 non-flow-through shares at $2.45 per share, with strategic investor Michael Gentile participating to maintain his stake.

Key Details

• Brokered LIFE Offering:

  • Lead Agent: Canaccord Genuity Corp. (sole bookrunner for a syndicate of agents).
  • Instrument: Up to 3,525,000 flow-through shares (FT shares).
  • Price: $3.40 per FT share.
  • Gross Proceeds: Up to $11,985,000.
  • Use of Proceeds: Gross proceeds from FT shares will be used to incur eligible Canadian exploration expenses (flow-through mining expenditures) related to the company's Canadian projects, to be renounced to subscribers effective Dec. 31, 2026.
  • Indemnification: The company will indemnify subscribers for additional taxes payable if qualifying expenditures are not renounced by Dec. 31, 2026, or are reduced by the Canada Revenue Agency.
  • Hold Period: No hold period for Canadian resident subscribers under the LIFE exemption.

• Concurrent Non-Brokered Private Placement:

  • Gross Proceeds: Up to $4,015,085.
  • Instrument: Up to 1,070,960 FT shares (at issue price) and up to 152,580 non-flow-through shares (NFT shares).
  • NFT Share Price: $2.45 per NFT share.
  • Use of Proceeds: Net proceeds from NFT shares to be used for general and administrative expenses and unallocated working capital over 12 months following closing.
  • Hold Period: Four-month hold period for Canadian resident subscribers.

• Strategic Participation:

  • Michael Gentile intends to participate in the offering to maintain his approximately 8.4% partially diluted interest.

• Closing and Regulatory:

  • Expected Closing: On or about Feb. 17, 2026.
  • Conditions: Subject to regulatory approvals, including conditional approval of the TSX Venture Exchange.
  • Jurisdiction: Offered to purchasers in Canada (except Quebec) for the LIFE portion; Canada and/or other qualifying jurisdictions for the non-brokered portion.

Notable Quotes

• None provided in the text.